Chugai Pharmaceutical

Tokyo, Japan Founded: 1925 • Age: 101 yrs Acquired By Roche
Innovative pharmaceutical products and services are developed and delivered.
Request Access

About Chugai Pharmaceutical

Chugai Pharmaceutical is a company based in Tokyo (Japan) founded in 1925 was acquired by Roche in October 2006.. Chugai Pharmaceutical has completed 1 acquisition, including Renalys.

  • Headquarter Tokyo, Japan
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Chugai Pharma Usa, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $8.04 B (USD)
    7.46
    as on Dec 31, 2025
  • Net Profit
    $2.77 B (USD)
    12.06
    as on Dec 31, 2025
  • EBITDA
    $3.97 B (USD)
    8.19
    as on Dec 31, 2025
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Roche

    (Oct 01, 2006)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Chugai Pharmaceutical
Headcount 200-500
Employee Profiles 10
Board Members and Advisors 10
Employee Profiles
People
Osamu Okuda
Representative Director, President & CEO
People
Paul Mignone
General Counsel
People
Vivian Mak
Finance And Accounting Manager
People
Darryl Minitelli
Accounting Manager CPA

Unlock access to complete

Board Members and Advisors
people
Yoshiaki Ohashi
Board Member
people
Christoph Franz
Director
people
Kenichi Masuda
Board Member
people
Mariko Y Momoi
Director

Unlock access to complete

Funding Insights of Chugai Pharmaceutical

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Chugai Pharmaceutical

Chugai Pharmaceutical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Roche. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Pharmaceuticals and diagnostics kits are developed for various diseases.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Chugai Pharmaceutical

Chugai Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Renalys. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Therapeutics for renal diseases are developed and launched by Renalys.
2023
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Chugai Pharmaceutical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Chugai Pharmaceutical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Chugai Pharmaceutical

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Chugai Pharmaceutical

Frequently Asked Questions about Chugai Pharmaceutical

When was Chugai Pharmaceutical founded?

Chugai Pharmaceutical was founded in 1925.

Where is Chugai Pharmaceutical located?

Chugai Pharmaceutical is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.

Who is the current CEO of Chugai Pharmaceutical?

Tatsuro Kosaka is the current CEO of Chugai Pharmaceutical.

What is the annual revenue of Chugai Pharmaceutical?

Annual revenue of Chugai Pharmaceutical is $8.04B as on Dec 31, 2025.

What does Chugai Pharmaceutical do?

Chugai Pharmaceutical was founded in 1925 and is headquartered in Tokyo, Japan, within the pharmaceutical sector. Research and development efforts are centered on creating medications for various health needs. Operations include collaborative partnerships to combine expertise in treatment creation and delivery. Patient-centric approaches are emphasized, alongside sustainable healthcare practices. Contributions are made to scientific progress and global health initiatives through these activities.

How many acquisitions has Chugai Pharmaceutical made?

Chugai Pharmaceutical has made 1 acquisition, including Renalys.

Who are Chugai Pharmaceutical's investors?

Chugai Pharmaceutical has 1 investor. Key investors include Roche.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available